Xortx Therapeutics Inc (XRTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Operating Expenses | 4,118 | 6,046 | 10,291 | 2,912 | 1,042 |
| Operating Income | -4,118 | -6,046 | -10,291 | -2,912 | -1,042 |
| Interest Expense | 0 | 0 | 0 | 5 | 10 |
| Other Income | 805 | 3,888 | 2,572 | 1,598 | 93 |
| Pre-tax Income | -3,313 | -2,158 | -7,719 | -1,318 | -959 |
| Net Income Continuous | -3,313 | -2,158 | -7,719 | -1,318 | -959 |
| Net Income | $-3,313 | $-2,158 | $-7,719 | $-1,318 | $-959 |
| EPS Basic Total Ops | -1.15 | -1.09 | -5.22 | -1.22 | -1.28 |
| EPS Basic Continuous Ops | -1.15 | -1.09 | -5.22 | -1.21 | -1.30 |
| EPS Diluted Total Ops | -1.15 | -1.09 | -5.22 | -1.22 | -1.28 |
| EPS Diluted Continuous Ops | -1.15 | -1.09 | -5.22 | -1.21 | -1.30 |
| EPS Diluted Before Non-Recurring Items | -1.15 | -2.95 | -4.95 | -2.52 | -0.09 |
| EBITDA(a) | $-4,001 | $-5,906 | $-10,233 | $-2,898 | $-1,027 |